Cat.#: ACPP-1243
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1647 | Human TUBB3 Protein (AC1647) | 2 µg | inquiry |
| ACPP-1711 | Human PEBP1 Protein (AC1711) | 10 µg | inquiry |
| ACPP-1660 | Mouse GDF7 Protein (AC1660) | 2 µg | inquiry |
| ACPP-1132 | Recombinant Human Calbindin Protein (AC1132) | 25 µl | inquiry |
| ACPP-1521 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1521) | 100 µg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1740 | Human RCAN1 Protein (AC1740) | 5 µg | inquiry |
| ACPP-1110 | Recombinant Human ROR1 Protein (6×His Tag) (AC1110) | 50 µg | inquiry |
| ACPP-1166 | Recombinant Human VCAM1 Protein (Fc Tag) (AC1166) | 50 µg | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.